Bugawan T L, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix C M, Petrone A, Buzzetti R, Pozzilli P, Erlich H A
Department of Human Genetics, Roche Molecular Systems, Alameda, CA 94501, USA.
Tissue Antigens. 2002 Jun;59(6):452-69. doi: 10.1034/j.1399-0039.2002.590602.x.
The genetic predisposition to type 1 diabetes among Filipinos was examined by PCR/SSOP HLA class I and II typing of 90 patients and 94 general population controls. The HLA-DRB1, DQB1, and the A, B, and C loci were typed using the reverse SSO probe line-blot method while the DPB1 and DPA1 loci were typed using the SSO probe dot blot method. The Filipino population has a distinctive frequency distribution of HLA class II alleles as well as linkage disequilibrium patterns: a DR-DQ haplotype, unique to Filipinos, contains a DRB1 allele (0405) positively associated with type 1 diabetes in other populations and DQA1 and DQB1 alleles (0101-0503) that are negatively associated in other populations. Specific DR-DQ haplotypes or alleles could be identified as susceptible, neutral or protective based on the distribution among Filipino patients and controls. The DR9 and DR3 haplotypes showed the most dramatic increase among patients (0.156 vs 0.063) and (0.172 vs 0.042), respectively. Among Filipinos, the DR3/9 genotype confers approximately the same risk as the well-known high-risk DR3/4 genotype, similar to that for DR3/3 and DR9/9. The common DR2 haplotype in the Philippines (DRB11502-DQB10502) was only slightly decreased in type 1 diabetic patients (0.200 in patients vs 0.270 in controls). Another DR2 haplotype, DRB11502-DQB10501, was significantly decreased among patients. In addition, haplotypes containing DQB106 alleles, such as the DRB10803-DQB10601 (OR = 0.1), are strongly protective. The DR4 allele group was also increased in Filipino patients compared to controls. In this population there is, as in other populations, a hierarchy of type 1 diabetes associations among the many different DR4 haplotypes (n = 15). The high-risk haplotypes in this population are the very rare DRB10405-DQB10302 and DQB10405-DQB10201, followed by the more common DRB10405-DQB10401 and DRB10405-DQB10402. The DRB10403-DQB10302 is protective. The DRB10405-DQB105031 haplotype, which is unique to Filipinos, appears to be "neutral". HLA-DPB10202 was significantly increased among patients (0.056 vs 0.011; with OR = 5.3); this increase does not appear to simply reflect linkage disequilibrium with high risk DR-DQ haplotypes. The observed distribution of HLA class II alleles among Filipino patients and controls strongly supports the notion that specific combinations of alleles at the DRB1, DQB1, DQA1, and DPB1 loci are critical in determining the risk for type 1 diabetes. Specific HLA class I alleles also show significant associations with type 1 diabetes in this population. HLA-A2402 and 2403 were increased among patients; however, 2407 was decreased. Inaddition, A 1101 was significantly decreased among patients (OR = 0.51). Moreover, these HLA-A associations do not appear attributable to linkage disequilibrium with the DR-DQ region. The allele B5801 was increased in patients while B1301 was decreased; both of these associations, however, reflected linkage disequilibrium with high-risk and with protective DR-DQ haplotypes, respectively. The HLA-C0102 and 0302 alleles were increased (0.089 vs 0.037 and 0.122 vs 0.064) while C1502 and 0702 (0.028 vs 0.080 and 0.217 vs 0.330) were decreased. The observed associations of C0102 and C1502 do not simply reflect linkage disequilibrium with high-risk DR-DQ haplotypes. Thus, specific HLA class I-A and C alleles were associated with type 1 diabetes in the Filipinos and may, in combination with high risk DR-DQ haplotypes, significantly modify disease risk.
通过对90例患者和94名普通人群对照进行PCR/SSOP HLA I类和II类分型,研究了菲律宾人患1型糖尿病的遗传易感性。采用反向SSO探针线性印迹法对HLA - DRB1、DQB1以及A、B和C位点进行分型,而采用SSO探针斑点印迹法对DPB1和DPA1位点进行分型。菲律宾人群具有独特的HLA II类等位基因频率分布以及连锁不平衡模式:一种菲律宾人特有的DR - DQ单倍型,包含在其他人群中与1型糖尿病呈正相关的DRB1等位基因(0405)以及在其他人群中呈负相关的DQA1和DQB1等位基因(0101 - 0503)。根据菲律宾患者和对照中的分布情况,特定的DR - DQ单倍型或等位基因可被确定为易感、中性或保护性。DR9和DR3单倍型在患者中增加最为显著,分别为(0.156对0.063)和(0.172对0.042)。在菲律宾人中,DR3/9基因型赋予的风险与众所周知的高风险DR3/4基因型大致相同,与DR3/3和DR9/9相似。菲律宾常见的DR2单倍型(DRB11502 - DQB10502)在1型糖尿病患者中仅略有下降(患者中为0.200,对照中为0.270)。另一种DR2单倍型DRB11502 - DQB10501在患者中显著下降。此外,含有DQB106等位基因的单倍型,如DRB10803 - DQB10601(OR = 0.1),具有很强的保护作用。与对照相比,菲律宾患者中DR4等位基因组也有所增加。在该人群中,与其他人群一样,在许多不同的DR4单倍型(n = 15)中存在1型糖尿病关联的层次结构。该人群中的高风险单倍型是非常罕见的DRB10405 - DQB10302和DQB10405 - DQB10201,其次是更常见的DRB10405 - DQB10401和DRB10405 - DQB10402。DRB10403 - DQB10302具有保护作用。菲律宾人特有的DRB10405 - DQB105031单倍型似乎是“中性的”。HLA - DPB10202在患者中显著增加(0.056对0.011;OR = 5.3);这种增加似乎并非仅仅反映与高风险DR - DQ单倍型的连锁不平衡。在菲律宾患者和对照中观察到的HLA II类等位基因分布有力地支持了这样一种观点,即DRB1、DQB1、DQA1和DPB1位点上等位基因的特定组合在决定1型糖尿病风险方面至关重要。特定的HLA I类等位基因在该人群中也显示出与1型糖尿病有显著关联。患者中HLA - A2402和2403增加;然而,A2407减少。此外,患者中A1101显著减少(OR = 0.51)。而且,这些HLA - A关联似乎并非归因于与DR - DQ区域的连锁不平衡。等位基因B5801在患者中增加而B1301减少;然而,这两种关联分别反映了与高风险和保护性DR - DQ单倍型的连锁不平衡。HLA - C0102和0302等位基因增加(0.089对0.037和0.122对0.064),而C1502和0702(0.028对0.080和0.217对0.330)减少。观察到的C0102和C*1502的关联并非仅仅反映与高风险DR - DQ单倍型的连锁不平衡。因此,特定的HLA I - A和C等位基因与菲律宾人的1型糖尿病相关,并且可能与高风险DR - DQ单倍型结合,显著改变疾病风险。